These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 8280861)

  • 41. Receptor reserve masks partial agonist activity of drugs in a cloned rat 5-hydroxytryptamine1B receptor expression system.
    Adham N; Ellerbrock B; Hartig P; Weinshank RL; Branchek T
    Mol Pharmacol; 1993 Mar; 43(3):427-33. PubMed ID: 8095694
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Age-related assessment of central 5-HT1A receptors following irreversible inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
    Keck J; Lakoski JM
    Brain Res; 1996 Jul; 728(1):130-4. PubMed ID: 8864308
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of experimental hypothyroidism on 5-HT1A, 5-HT2A receptors, 5-HT uptake sites and tryptophan hydroxylase activity in mature rat brain1.
    Kulikov A; Moreau X; Jeanningros R
    Neuroendocrinology; 1999 Jun; 69(6):453-9. PubMed ID: 10364698
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effects of hypothyroidism on 5-HT1A and 5-HT2A receptors and the serotonin transporter protein in the rat brain.
    Kulikov AV; Jeanningro R
    Neurosci Behav Physiol; 2001; 31(4):445-9. PubMed ID: 11508497
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effect of hypothyroidism on 5-HT1A-, 5-HT2A-receptors and serotonin transporter in the rat brain].
    Kulikov AV; Jeanningro R
    Ross Fiziol Zh Im I M Sechenova; 2000 Mar; 86(3):312-9. PubMed ID: 10808528
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Time-course of recovery of 5-HT1A receptors and changes in 5-HT1A receptor mRNA after irreversible inactivation with EEDQ.
    Raghupathi RK; Brousseau DA; McGonigle P
    Brain Res Mol Brain Res; 1996 Jun; 38(2):233-42. PubMed ID: 8793111
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cellular localization of serotonin 1A, 1B and uptake sites in cingulate cortex of the rat.
    Crino PB; Vogt BA; Volicer L; Wiley RG
    J Pharmacol Exp Ther; 1990 Feb; 252(2):651-6. PubMed ID: 2138221
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vivo estimates of efficacy at 5-HT1A receptors: effects of EEDQ on the ability of agonists to produce lower-lip retraction in rats.
    Koek W; Assié MB; Zernig G; France CP
    Psychopharmacology (Berl); 2000 May; 149(4):377-87. PubMed ID: 10867965
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of a chronic lithium treatment on cortical serotonin uptake sites and 5-HT1A receptors.
    Carli M; Afkhami-Dastjerdian S; Reader TA
    Neurochem Res; 1997 Apr; 22(4):427-35. PubMed ID: 9130253
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alterations in serotonin receptor subtypes in ethanol-dependent rats.
    Ulrichsen J
    Alcohol Alcohol; 1991; 26(5-6):567-73. PubMed ID: 1839497
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential receptor reserve for 5-HT1A receptor-mediated regulation of plasma neuroendocrine hormones.
    Meller E; Bohmaker K
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1246-52. PubMed ID: 7996433
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ; Bervoets K; Colpaert FC
    J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [125I]5-iodo-6-nitroquipazine: a potent and selective ligand for the 5-hydroxytryptamine uptake complex. I. In vitro studies.
    Mathis CA; Taylor SE; Biegon A; Enas JD
    Brain Res; 1993 Aug; 619(1-2):229-35. PubMed ID: 8374781
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Binding of 5-HT1A receptor and 5-HT transporter ligands in rat cortex and hippocampus following cholinergic and serotonergic lesions.
    Lawrence JA; Olverman HJ; Shirakawa K; Kelly JS; Butcher SP
    Brain Res; 1993 May; 612(1-2):326-9. PubMed ID: 7687192
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effects of the peptide-coupling agent, EEDQ, on 5-HT2A receptor binding and function in rat frontal cortex.
    Kettle CJ; Cheetham SC; Martin KF; Prow MR; Heal DJ
    Neuropharmacology; 1999 Sep; 38(9):1421-30. PubMed ID: 10471096
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 5-HT1B and 5-HT2 serotonin binding sites in cultured Wistar-Kyoto rat aortic smooth muscle cells.
    Jazayeri A; Meyer WJ; Kent TA
    Eur J Pharmacol; 1989 Oct; 169(1):183-7. PubMed ID: 2532143
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of 5-hydroxytryptamine1B receptors in rat spinal cord via [125I]iodocyanopindolol binding and inhibition of [3H]-5-hydroxytryptamine release.
    Matsumoto I; Combs MR; Jones DJ
    J Pharmacol Exp Ther; 1992 Feb; 260(2):614-26. PubMed ID: 1738111
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA) occurs through the stimulation of serotonin receptors and transporter.
    Kramer HK; Poblete JC; Azmitia EC
    Neuropsychopharmacology; 1997 Sep; 17(3):117-29. PubMed ID: 9272479
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypericum perforatum L. extract does not inhibit 5-HT transporter in rat brain cortex.
    Gobbi M; Valle FD; Ciapparelli C; Diomede L; Morazzoni P; Verotta L; Caccia S; Cervo L; Mennini T
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):262-9. PubMed ID: 10543427
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of [3H]paroxetine and [3H]cyanoimipramine for quantitative measurement of serotonin transporter sites in human brain.
    Gurevich EV; Joyce JN
    Neuropsychopharmacology; 1996 May; 14(5):309-23. PubMed ID: 8703300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.